We therefore recommend the use of aggressive early treatments, including radiotherapy and/or TMZ, to reduce residual tumor growth in patients with refractory pituitary adenoma characterized by a high Ki-67 index, rapid growth, early and frequent recurrence, and resistance to current treatments. This evidence concerns the gene MKI67 and neoplasm.